Maria do Carmo Nabuco de Almeida Braga

Part of Rzb Participaçoes Ltda, Fundação Ary Frauzino Para Pesquisa e Controle do Câncer operates a hospital specializing in cancer treatment. The company is based in Rio de Janeiro, Brazil. The Brazilian company was founded in 1991 by Ulpio Paulo de Miranda, Magda Cortes Rodrigues Rezende, Jayme Brandao de Marsillac, Marcos Moraes. Fundação Ary Frauzino Para Pesquisa e Controle do Câncer was acquired by Oncoclínicas do Brasil Serviços Médicos SA on August 19, 2020 for $27.14 million.

Part of Rzb Participaçoes Ltda, Fundação Ary Frauzino Para Pesquisa e Controle do Câncer operates a hospital specializing in cancer treatment. The company is based in Rio de Janeiro, Brazil. The Brazilian company was founded in 1991 by Ulpio Paulo de Miranda, Magda Cortes Rodrigues Rezende, Jayme Brandao de Marsillac, Marcos Moraes. Fundação Ary Frauzino Para Pesquisa e Controle do Câncer was acquired by Oncoclínicas do Brasil Serviços Médicos SA on August 19, 2020 for $27.14 million.

Part of Rzb Participaçoes Ltda, Fundação Ary Frauzino Para Pesquisa e Controle do Câncer operates a hospital specializing in cancer treatment. The company is based in Rio de Janeiro, Brazil. The Brazilian company was founded in 1991 by Ulpio Paulo de Miranda, Magda Cortes Rodrigues Rezende, Jayme Brandao de Marsillac, Marcos Moraes. Fundação Ary Frauzino Para Pesquisa e Controle do Câncer was acquired by Oncoclínicas do Brasil Serviços Médicos SA on August 19, 2020 for $27.14 million.

Part of Rzb Participaçoes Ltda, Fundação Ary Frauzino Para Pesquisa e Controle do Câncer operates a hospital specializing in cancer treatment. The company is based in Rio de Janeiro, Brazil. The Brazilian company was founded in 1991 by Ulpio Paulo de Miranda, Magda Cortes Rodrigues Rezende, Jayme Brandao de Marsillac, Marcos Moraes. Fundação Ary Frauzino Para Pesquisa e Controle do Câncer was acquired by Oncoclínicas do Brasil Serviços Médicos SA on August 19, 2020 for $27.14 million.

Part of Rzb Participaçoes Ltda, Fundação Ary Frauzino Para Pesquisa e Controle do Câncer operates a hospital specializing in cancer treatment. The company is based in Rio de Janeiro, Brazil. The Brazilian company was founded in 1991 by Ulpio Paulo de Miranda, Magda Cortes Rodrigues Rezende, Jayme Brandao de Marsillac, Marcos Moraes. Fundação Ary Frauzino Para Pesquisa e Controle do Câncer was acquired by Oncoclínicas do Brasil Serviços Médicos SA on August 19, 2020 for $27.14 million.

Part of Rzb Participaçoes Ltda, Fundação Ary Frauzino Para Pesquisa e Controle do Câncer operates a hospital specializing in cancer treatment. The company is based in Rio de Janeiro, Brazil. The Brazilian company was founded in 1991 by Ulpio Paulo de Miranda, Magda Cortes Rodrigues Rezende, Jayme Brandao de Marsillac, Marcos Moraes. Fundação Ary Frauzino Para Pesquisa e Controle do Câncer was acquired by Oncoclínicas do Brasil Serviços Médicos SA on August 19, 2020 for $27.14 million.

Brasilcap Capitalização SA provides investment fund management services. The company was founded in 1995 and is headquartered in Rio de Janeiro, Brazil.

Brasilcap Capitalização SA provides investment fund management services. The company was founded in 1995 and is headquartered in Rio de Janeiro, Brazil.

Brasilcap Capitalização SA provides investment fund management services. The company was founded in 1995 and is headquartered in Rio de Janeiro, Brazil.

Brasilcap Capitalização SA provides investment fund management services. The company was founded in 1995 and is headquartered in Rio de Janeiro, Brazil.